Athenex (ATNX) Announces Publication of Data from Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients with Metastatic Breast Cancer in the Journal of Clin

Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the publication of their manuscript, “Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients with Metastatic Breast Cancer”. The article, along with results, can be found on the American Society of Clinical Oncology Journal’s website at this link.

“We are pleased with the publication of the phase 3 data, which show that oral paclitaxel plus encequidar significantly improves tumor response in patients with metastatic breast cancer, compared to IV administration. Positive trends were observed in progression free survival and overall survival,” said Hope S. Rugo, MD, Professor of Medicine, University of California San Francisco Comprehensive Cancer Center. “With oral administration of paclitaxel plus encequidar, we observed less frequent and less severe neuropathy, which is often a limiting toxicity with IV taxanes. In patients with abnormal liver function, we identified a predisposition to early neutropenia and infections in patents with elevated liver enzymes at baseline, allowing for better toxicity management moving forward. We believe that for appropriate patients with advanced or metastatic breast cancer, this could potentially be an effective at home treatment option.”

You May Also Be Interested In

• Day One Biopharmaceuticals' (DAWN) OJEMDA Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
• Hyzon Motors (HYZN) Announces Resignation of President, North America Pat Griffin
• Luminar Technologies (LAZR) Began Delivering LIDARs for Volvo EX90